P04 – Newborn affected by noxious substances transmitted via placenta or breast milk
Coding Notes
Active
Non-billable / Non-specific, not valid for HIPAA-covered transactions
Code First
any current condition in newborn, if applicable
Tyoe 2 Excludes
congenital malformations (Q00-Q99)
encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)
newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
Includes
nonteratogenic effects of substances transmitted via placenta
Child Codes
Sibling Codes
View in Tabular
| Code | Title |
|---|---|
| P00-P96 | Certain conditions originating in the perinatal period (P00-P96) |
| P00-P04 | Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery (P00-P04) |
| P04 |
Newborn affected by noxious substances transmitted via placenta or breast milk
Type 2 Excludes
congenital malformations (Q00-Q99)
encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)
newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
Includes
nonteratogenic effects of substances transmitted via placenta
Code First
any current condition in newborn, if applicable
|
| P04.0 | Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery |
| P04.1 | Newborn affected by other maternal medication |
| P04.11 | Newborn affected by maternal antineoplastic chemotherapy |
| P04.12 | Newborn affected by maternal cytotoxic drugs |
| P04.13 | Newborn affected by maternal use of anticonvulsants |
| P04.14 | Newborn affected by maternal use of opiates |
| P04.15 | Newborn affected by maternal use of antidepressants |
| P04.16 | Newborn affected by maternal use of amphetamines |
| P04.17 | Newborn affected by maternal use of sedative-hypnotics |
| P04.1A | Newborn affected by maternal use of anxiolytics |
| P04.18 | Newborn affected by other maternal medication |
| P04.19 | Newborn affected by maternal use of unspecified medication |
| P04.2 | Newborn affected by maternal use of tobacco |
| P04.3 | Newborn affected by maternal use of alcohol |
| P04.4 | Newborn affected by maternal use of drugs of addiction |
| P04.40 | Newborn affected by maternal use of unspecified drugs of addiction |
| P04.41 | Newborn affected by maternal use of cocaine |
| P04.42 | Newborn affected by maternal use of hallucinogens |
| P04.49 | Newborn affected by maternal use of other drugs of addiction |
| P04.5 | Newborn affected by maternal use of nutritional chemical substances |
| P04.6 | Newborn affected by maternal exposure to environmental chemical substances |
| P04.8 | Newborn affected by other maternal noxious substances |
| P04.81 | Newborn affected by maternal use of cannabis |
| P04.89 | Newborn affected by other maternal noxious substances |
| P04.9 | Newborn affected by maternal noxious substance, unspecified |